Department of Cardiology, University Hospital Besancon, Boulevard Fleming, Besancon 25000, France.
EA3920, University of Franche-Comté, Besancon 25000, France.
Eur Heart J Acute Cardiovasc Care. 2021 Apr 8;10(2):207-215. doi: 10.1093/ehjacc/zuab010.
We estimated the 2020 European Society of Cardiology-Acute Cardio Vascular Care (ESC-ACVC) quality indicators (QI) for the management of acute myocardial infarction, from three existing registries to determine the feasibility of assessment, room for improvement, association with outcomes, and suitability for centre benchmarking.
Data were extracted from three French nationwide registries, namely FAST-MI 2005, 2010, and 2015. Feasibility of assessment and room for improvement were estimated by the denominator (patients in whom QI could be measured) and numerator (patients who satisfied the QI, among those eligible). Associations between composite QIs (CQIs) and mortality were assessed by multivariate analysis. Centre benchmarking was based on the centres mean CQI, vs. the national mean. The 2020 QIs were measured in 12 660/13 130 patients from FAST-MI. Measurement feasibility ranged from 15% to 100% with greater potential for implementation with the 2020 QI set. The mean (±SD) value of the opportunity-based CQI was 0.72 ± 0.01 and attainment of the all-or-none CQI 8.5%. Both CQIs were associated with adjusted 1-year mortality. Centre categorization into low, intermediate, and high quality was feasible, and distinguished centres with differing mortality.
Most of the 2020 QI can be measured from existing registries in all domains but not in the patient's satisfaction domain. This assessment shows potential for implementation. Both CQIs were inversely associated with one-year mortality and centre benchmarking was feasible.
我们从三个现有的注册研究中评估了 2020 年欧洲心脏病学会-急性心血管护理(ESC-ACVC)急性心肌梗死管理的质量指标(QI),以确定评估的可行性、改进的空间、与结局的关联以及中心基准测试的适用性。
数据从三个法国全国性注册研究中提取,即 FAST-MI 2005、2010 和 2015。通过分母(可测量 QI 的患者)和分子(符合 QI 的患者,在合格患者中)评估评估的可行性和改进空间。通过多变量分析评估复合 QI(CQI)与死亡率之间的关联。中心基准测试基于中心的平均 CQI 与全国平均水平的比较。2020 年 QI 在 FAST-MI 的 12660/13130 名患者中进行了测量。测量可行性范围从 15%到 100%,随着 2020 年 QI 集的实施,潜在的改进空间更大。基于机会的 CQI 的平均值(±标准差)为 0.72±0.01,全部或无的 CQI 达标率为 8.5%。这两个 CQI 都与调整后的 1 年死亡率相关。将中心分为低、中、高质量的分类是可行的,并区分了死亡率不同的中心。
2020 年的大多数 QI 可以从所有领域的现有注册研究中进行测量,但在患者满意度领域不行。这种评估显示出实施的潜力。这两个 CQI 与一年死亡率呈负相关,中心基准测试是可行的。